The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome
Open accessAbstract
Background —Corticotropin-releasing hormone (CRH) plays a key role in modulating intestinal motility in stressed animals. Aims —To evaluate the effect of CRH on intestinal motility in humans and to determine whether patients with irritable bowel syndrome (IBS) have an exaggerated response to CRH. Subjects —Ten IBS patients diagnosed by Rome criteria and 10 healthy controls. Methods —CRH (2 μg/kg) was intravenously administered during duodenal and colonic manometry and plasma adrenocorticotropic hormone (ACTH) was measured by radioimmunoassay. Results —CRH induced motility of the descending colon in both groups (p<0.001) and induced greater motility indexes in IBS patients than in controls (p<0.05). CRH produced duodenal phase III motor activity in 80% of the subjects and duodenal dysmotility in 40% of IBS patients. Abdominal symptoms evoked by CRH in IBS patients lasted significantly longer than those in controls (p<0.05). CRH induced significant increases in plasma ACTH levels in both groups (p<0.001) and produced significantly higher plasma ACTH levels in IBS patients than in controls (p<0.001). Conclusion —Human intestinal motility is probably modulated by exogenous CRH. The brain-gut in IBS patients may have an exaggerated response to CRH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“This is the first study confirming that exogenous CRH can produce considerable changes in phasic contractions in human colon and small intestine. CRH is a peptide containing 41 amino acids,”
BackgroundVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
Physiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142
Agréus, L., Svärdsudd, K., Nyrén, O., & Tibblin, G. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90373-9 · Cited by 686
Altered small bowel motility in irritable bowel syndrome is correlated with symptoms
Kellow, J. E., & Phillips, S. F. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90620-2 · Cited by 464
Lovenberg, T. W., Chalmers, D. T., Liu, C., & Souza, E. B. D. (1995) · Endocrinology · doi:10.1210/en.136.9.4139 · Cited by 458
The functional gastrointestinal disorders
Olden, K. W. (1997) · General Hospital Psychiatry · doi:10.1016/s0163-8343(96)00109-0 · Cited by 438
Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor
Perrin, M. H., Donaldson, C. J., Chen, R., Lewis, K. A., & Vale, W. (1993) · Endocrinology · doi:10.1210/en.133.6.3058 · Cited by 437
Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings.
Stanghellini, V, Camilleri, M., & Malagelada, J. R. (1987) · Gut · doi:10.1136/gut.28.1.5 · Cited by 323
Cited by
The functional gastrointestinal disorders and the Rome III process
Drossman, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.008 · Cited by 2,416
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384
Guidelines on the irritable bowel syndrome: mechanisms and practical management
Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N., et al. (2007) · Gut · doi:10.1136/gut.2007.119446 · Cited by 818
Dinan, T. G., Quigley, E. M. M., Ahmed, S. M. M., Scully, P., O’Brien, S., O’Mahony, L., O’Mahony, S., Shanahan, F., & Keeling, P. W. N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.033 · Cited by 636
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Van Oudenhove, L., Levy, R. L., Crowell, M. D., Drossman, D. A., Halpert, A. D., Keefer, L., Lackner, J. M., Murphy, T. B., & Naliboff, B. D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.027 · Cited by 512
V. Stress and irritable bowel syndrome
Mayer, E. A., Naliboff, B. D., Chang, L., & Coutinho, S. V. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.4.g519 · Cited by 413
Habib, K. E., Weld, K. P., Rice, K. C., Pushkas, J., Champoux, M., Listwak, S., Webster, E. L., Atkinson, A. J., Schulkin, J., Contoreggi, C., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.6079 · Cited by 403
Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum
Guilarte, M., Santos, J., de Torres, I., Alonso, C., Vicario, M., Ramos, L., Martinez, C., Casellas, F., Saperas, E., & Malagelada, J. R. (2007) · Gut · doi:10.1136/gut.2006.100594 · Cited by 385
Corticotropin-releasing factor receptors and stress-related alterations of gut motor function
Taché, Y., & Bonaz, B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30085 · Cited by 375
Irritable bowel syndrome: a little understood organic bowel disease?
Talley, N. J., & Spiller, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09712-x · Cited by 308
Biopsychosocial Model of Irritable Bowel Syndrome
Tanaka, Y., Kanazawa, M., Fukudo, S., & Drossman, D. A. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.2.131 · Cited by 304
Self-citationPosserud, I., Agerforz, P., Ekman, R., Björnsson, E. S., Abrahamsson, H., & Simrén, M. (2004) · Gut · doi:10.1136/gut.2003.017962 · Cited by 297
Sagami, Y., Shimada, Y., Tayama, J., Nomura, T., Satake, M., Endo, Y., Shoji, T., Karahashi, K., Hongo, M., & Fukudo, S. (2004) · Gut · doi:10.1136/gut.2003.018911 · Cited by 291
Self-citationTaché, Y., & Perdue, M. H. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1743-3150.2004.00490.x · Cited by 282
The Role of Stress on Physiologic Responses and Clinical Symptoms in Irritable Bowel Syndrome
Chang, L. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.032 · Cited by 267
Dysregulation of the hypothalamic‐pituitary‐adrenal (HPA) axis in irritable bowel syndrome
Chang, L., Sundaresh, S., Elliott, J., Anton, P. A., Baldi, P., Licudine, A., Mayer, M., Vuong, T., Hirano, M., Naliboff, B. D., et al. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01171.x · Cited by 253
Tak, L. M., Cleare, A. J., Ormel, J., Manoharan, A., Kok, I. C., Wessely, S., & Rosmalen, J. G. M. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.02.002 · Cited by 230
An Evidence-Based Systematic Review on the Management of Irritable Bowel Syndrome
Brandt, L. J., Chey, W. D., Foxx-Orenstein, A. E., Quigley, E. M. M., Schiller, L. R., Schoenfeld, P. S., Spiegel, B. M., Talley, N. J., & Moayyedi, P. (2009) · American Journal of Gastroenterology · doi:10.14309/00000434-200901001-00002 · Cited by 225
A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction
Keefer, L., Ballou, S. K., Drossman, D. A., Ringstrom, G., Elsenbruch, S., & Ljótsson, B. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.09.015 · Cited by 213
The immune system in irritable bowel syndrome
Barbara, G., Cremon, C., Carini, G., Bellacosa, L., Zecchi, L., Giorgio, R. D., Corinaldesi, R., & Stanghellini, V. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.4.349 · Cited by 211
“1).(61,66) Activation of CRF-receptor 1 in the periphery caus-”
Fadgyas-Stanculete, M., Buga, A.-M., Popa-Wagner, A., & Dumitrascu, D. L. (2014) · Journal of Molecular Psychiatry · doi:10.1186/2049-9256-2-4 · Cited by 197
Gut memories: Towards a cognitive neurobiology of irritable bowel syndrome
Kennedy, P. J., Clarke, G., Quigley, E. M. M., Groeger, J. A., Dinan, T. G., & Cryan, J. F. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.07.001 · Cited by 193
Hellström, P. M., Näslund, E., Edholm, T., Schmidt, P. T., Kristensen, J., Theodorsson, E., Holst, J. J., & Efendic, S. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.01079.x · Cited by 160
Brain and gut CRF signaling: biological actions and role in the gastrointestinal tract
Tache, Y., Larauche, M., Yuan, P.-Q., & Million, M. (2018) · Current Molecular Pharmacology · doi:10.2174/1874467210666170224095741 · Cited by 147
“There are also convergent reports that systemic bolus injection of CRF lowers pain threshold to repetitive rectal distensions and enhances the intensity of discomfort sensation in healthy human subjects [274, 279, 280].”
BackgroundGareau, M. G., Jury, J., Yang, P. C., MacQueen, G., & Perdue, M. H. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000190577.62426.45 · Cited by 139
“Early life stressors also increase the risk of intestinal disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease in adulthood (2).”
InfluentialIrritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy.
(2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8807 · Cited by 132
Hiroi, N., Wong, M. L., Licinio, J., Park, C., Young, M., Gold, P. W., Chrousos, G. P., & Bornstein, S. R. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000908 · Cited by 124
Aizawa, E., Sato, Y., Kochiyama, T., Saito, N., Izumiyama, M., Morishita, J., Kanazawa, M., Shima, K., Mushiake, H., Hongo, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.104 · Cited by 116
Self-citationVicario, M., Alonso, C., Guilarte, M., Serra, J., Martínez, C., González-Castro, A. M., Lobo, B., Antolín, M., Andreu, A. L., García-Arumí, E., et al. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.05.005 · Cited by 92
“Moreover, the view of IBS as a stress sensitive disorder is particularly highlighted because many of the above stress-mediated responses appear to be somehow magnified in these patients (Welgan et al., 1988; Fukudo et al., 1998; Murray et al., 2004; Alonso et al., 2004).”
BackgroundMizrahi, M. C., Reicher-Atir, R., Levy, S., Haramati, S., Wengrower, D., Israeli, E., & Goldin, E. (2012) · Psychology & Health · doi:10.1080/08870446.2012.691169 · Cited by 83
“Stress has been defined as any influence that disturbs the natural equilibrium of the body, and includes a variety of illnesses and emotional disturbances (Cox, 1978 ).”
BackgroundIs irritable bowel syndrome an inflammatory disorder?
De Giorgio, R., & Barbara, G. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0073-0 · Cited by 64
The microbiome and disorders of the central nervous system
Felice, V. D., & O'Mahony, S. M. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.06.016 · Cited by 60
“The enhanced activation of the hypothalamic pituitary adrenal (HPA) axis associated with an alteration of the immune system as well as increased intestinal permeability are commonly seen in IBS patients (Fukudo et al., 1998; Dinan et al., 2006; Camilleri and Gorman, 2007).”
Choghakhori, R., Abbasnezhad, A., Amani, R., & Alipour, M. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4554-6 · Cited by 48
Lydiard, R. B. (2005) · CNS Spectrums · doi:10.1017/s1092852900019878 · Cited by 45
Recent developments in the therapy of irritable bowel syndrome
Saad, R. J., & Chey, W. D. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.117 · Cited by 21
Review: Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome
Gaman, A., Bucur, M. C., & Kuo, B. (2009) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x08103656 · Cited by 12
“05) than the control group [Fukudo et al. 1998].”
Background
Metadata
- Authors
- Fukudo, S., Nomura, T., & Hongo, M.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1998-06-01
- Volume
- 42
- Issue
- 6
- Pages
- 845-849
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2137002278
- Cited by
- 387
- References
- 40
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.